Trial Details
COMPLETEDBasic Information
| Clinical ID | c3595 |
|---|---|
| Identifier | NCT01809275 |
| Trial Title | Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Inflammatory Bowel Disease |
| Interventions | DRUG: QBECO|DRUG: Placebo |
Participant Information
| Sponsor | Qu Biologics Inc. |
|---|---|
| City | Alberta |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2013-03 |
|---|---|
| Primary Completion Date | 2016-02 |
| Completion Date | 2016-07 |